CTAG2 antibody
Principal name
CTAG2 antibody
Alternative names for CTAG2 antibody
Cancer/testis antigen 2, CT2, NY-ESO-2, ESO2, LAGE1, CT6.2, L antigen family member 1, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2
SwissProt ID
O75638 (Human)
Gene ID
30848 (CTAG2)
Ncbi ID
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB)
Background of CTAG2 antibody
- Kit Component:
- - KN201190G1, CTAG2 gRNA vector 1 in pCas-Guide vector
- KN201190G2, CTAG2 gRNA vector 2 in pCas-Guide vector
- KN201190D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Detection limit for recombinant GST tagged CTAG2 is approximately 0.1ng/ml as a capture antibody.
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP311659 | CTAG2 (transcript variant 1) |
||||
| Recombinant protein of human cancer/testis antigen 2 (CTAG2), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY406703 | CTAG2 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |